Overview Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Sign: In combination with chemotherapy, for the remedy of adult sufferers with locally recurrent unresectable or metastatic triple-detrimental breast cancer who have not acquired prior chemotherapy for metastatic disorder and whose tumours Convey programmed mobile Dying-ligand one (combined favourable score ≥ ten) as d... https://jeffj211czw6.59bloggers.com/profile